neutral
reduc
prefer compani
segment avail
reason valuat
protect us immigr
tp
consensu valu stock
ep vs consensu
valu non-gaap
recent correct opportun buy
growth moder price ep growth still
healthi valuat turn reason
action upgrad buy cut tp impli upsid
weaker growth bfsi margin cut guidanc neg
cut revenu compound-annual-growth-rate organ par
bfsi drag deterior like
limit us client show improv possibl drag
non-u larg client normalis growth product commun
revenu continu strong double-digit past
quarter q-q momentum healthcar q-q decent even
y-i still slow view provid base growth view
ctsh strength healthcar revenu contribut medium-
term posit margin see improv trajectori expect like
increas buy-back repatri fund non-india market
easier post-u tax reform help post similar better ep
compound-annual-growth-rate vs info/tc though
limit immedi trigger believ risk reward favor
stock past six month valuat
discount info/tcs/acn tp slightli lower
growth moder upgrad buy neutral
defens earn rise margin provid cushion
ytd sale info/tc ex-bench cost
calcul still scope leverag reach guid
margin non-gaap provid ep defens even growth
disappoint expect gaap/non-gaap ebit margin improv
vs coupl ep
accret buyback fund strong gener ltm
ep cut tp cut vs earlier
ep estim lower minor growth moder expect
revenue/ep compound-annual-growth-rate ebit margin
tp base forward gaap
ep rise buy-back quantum effort modifi
current growth vs margin trade-off could posit trigger downsid
risk us immigr tighten slower anticip growth
compani data next page compani data detail price/index chart
appendix analyst certif import disclosur statu non-u analyst
data cogniz
rel
good sold
earn tax
net profit tax
transfer reserv
valuat ratio
chang work capit
cash-flow oper
reduct invest
dec lt asset
inc lt liabil
cf invest act
cf financi act
dec
equiti reserv
recent correct opportun
fig growth differenti info/tc narrow
growth differenti narrow vs info/tc organ basi
expect grow compound-annual-growth-rate par
fig product cmt revenu growth trend y-i
product cmt revenu seen strong momentum
double-digit growth last quarter outlook remain posit
driven mfg/retail product commun other
bfsi drag growth similar peer see
bottom growth bfsi us client show
improv non-u like normal view
fig sale comparison peer
think scope leverag reach non-gaap ebit
margin band cost current lower
vs peer provid defens earn
usd revenu ep compound-annual-growth-rate larg in-lin better peer
post correct past six month
valuat discount vs info/tc risk reward attract
trade forward ep averag trade
histori valu stdev averag arriv
tp
fig organ growth calcul
estim expect post overal revenu compound-annual-growth-rate organ expect post overal
growth y-i organ growth y-i usd
acq prior
ep cut tp vs earlier upgrad
neutral buy
revenu estim lower due cut guidanc weak
bfsi estim usd revenu compound-annual-growth-rate organ
margin estim larg unchang continu expect ebit
margin rang slightli lower vs guidanc
vs result ep estim lower
result margin tp cut vs earlier ep cut
due higher loss fx due inr depreci non-recur
natur
stock trade forward ep discount vs
info/tc despit similar usd revenue/ep compound-annual-growth-rate think attract henc
upgrad stock buy new tp impli upsid hclt
remain top pick follow buy
fig chang estim
weak bfsi guidanc cut neg
revenu q-q growth vs guidanc vs
our/bloomberg expect growth compar usd q-q growth
wpro
non-gaap oper margin vs vs our/consensu
estim
gaap ebit margin vs vs estim
non-gaap ep vs guidanc least our/consensu
estim
adopt new revenu standard posit impact revenu
incom oper dilut earn per share
per share
headcount grew q-q
buy-back repurchas addit share consider
compani alreadi repurchas
lower usd revenu growth guidanc vs
earlier vs expect guidanc impli growth
consensu estim revenu growth
retain non-gaap ep guidanc least
vertic bfsi q-q manufactur q-q healthcar q-q
geographi north america q-q europ q-q row q-q
digit digit contribut revenu grew low rang
margin busi higher compani averag
product resourc growth product driven strong momentum
retail manufactur within retail tradit retail invest digit
initi compet amazon drive omni-channel experi
personalis within manufactur client invest iot ai data
analyt facilit decis make improv effici
bfsi growth weak bfsi driven pressur run-sid busi
larger client especi uk apac higher invest
digit client like off-set pressur tradit busi
healthcar compani see demand area improv effici
advanc patient care also expand capabl across provid
network traction remain healthi
ebit margin remain track achiev non-gaap ebit margin
guidanc perform like driven optimis
pyramid oper effici focu higher valu servic digit
reassess less profit opportun off-set wage hike
promot
valuat methodolog risk
target price base one-year forward ep estim
target price-to-earnings multipl discount histor averag
downsid risk includ slower growth anticip inabl deliv
expect margin improv us immigr tighten relat impact
fig actual vs estim
product resourc
product resourc
hexaw
note repres hexw
bloomberg nomura estim note price octob except octob
ashwin mehta rishit parikh herebi certifi view express research report accur reflect
person view subject secur issuer refer research report part
compens directli indirectli relat specif recommend view express
research report part compens tie specif invest bank transact perform
nomura secur intern inc plc nomura group compani
